project . 2018 - 2021 . On going

PANBioRA

Personalized And/Or Generalized Integrated Biomaterial Risk Assessment
Open Access mandate for Publications and Research DataOpen Access mandate for ... European Commission
  • Funder: European CommissionProject code: 760921 Call for proposal: H2020-NMBP-2017-two-stage
  • Funded under: H2020 | RIA Overall Budget: 7,992,470 EURFunder Contribution: 7,992,470 EUR
  • Status: On going
  • Start Date
    01 Jan 2018
    End Date
    31 Dec 2021
  • Detailed project information (CORDIS)
Description
PANBioRA aims at providing a comprehensive solution for the time- and cost-effective risk assessment of i) new biomaterials under health or disease states or ii) a given biomaterial for each patient in a personalized manner. It will standardize the evaluation of biomaterials and open the venue for pre-implantation, personalized diagnostics for biomaterial based applications. PANBioRA will provide a modular platform to assess risks at different aspects and length scales. This comprises antibody response, cytotoxicity/genotoxicity at cell level, systemic and local effects at tissue and connected tissues (organ-on-a-chip) level. Moreover, physicochemical and biomec...
Description
PANBioRA aims at providing a comprehensive solution for the time- and cost-effective risk assessment of i) new biomaterials under health or disease states or ii) a given biomaterial for each patient in a personalized manner. It will standardize the evaluation of biomaterials and open the venue for pre-implantation, personalized diagnostics for biomaterial based applications. PANBioRA will provide a modular platform to assess risks at different aspects and length scales. This comprises antibody response, cytotoxicity/genotoxicity at cell level, systemic and local effects at tissue and connected tissues (organ-on-a-chip) level. Moreover, physicochemical and biomec...
Any information missing or wrong?Report an Issue